Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practical uropharmacology.

A J Wein1

  • 1Division of Urology, University of Pennsylvania School of Medicine, Philadelphia.

The Urologic Clinics of North America
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

This review explores drug therapies for urinary incontinence, focusing on reducing bladder contractions, enhancing outlet resistance, and managing the condition. It evaluates the effectiveness of different treatments for these specific incontinence types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary symptoms: broadening the horizons for the copeptin assay.

Journal of endocrinological investigation·2019
Same author

Nocturia: current concepts and future perspectives.

Acta physiologica (Oxford, England)·2012
Same author

Sympathetic innervation and chemical sympathectomy of canine bladder.

Urology·2011
Same author

Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy?

Urology·2008
Same author

Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience.

Journal of vascular and interventional radiology : JVIR·2006
Same author

Transitional cell carcinoma of the fossa navicularis in a man with preexisting adenocarcinoma of the prostate.

Urologia internationalis·2006
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Area of Science:

  • Urology
  • Pharmacology
  • Gerontology

Background:

  • Urinary incontinence is a prevalent condition affecting quality of life.
  • Pharmacological interventions are a cornerstone of incontinence management.
  • Treatment strategies target different pathophysiological mechanisms.

Purpose of the Study:

  • To review the efficacy of pharmacotherapy for urinary incontinence.
  • To categorize treatments based on their mechanism of action: reducing bladder contractility, increasing outlet resistance, or circumventing the problem.
  • To provide an overview of drug and other therapeutic options.

Main Methods:

  • Literature review of existing studies on incontinence pharmacotherapy.
  • Categorization of therapies based on their primary effect on bladder function or outlet resistance.

Related Experiment Videos

  • Synthesis of evidence regarding the effectiveness of various treatments.

    • Main Results:

    • Various drug classes demonstrate efficacy in managing different types of urinary incontinence.
    • Therapies targeting bladder contractility include anticholinergics and beta-3 agonists.
    • Agents increasing outlet resistance and behavioral therapies are also discussed.

    Conclusions:

    • Pharmacotherapy offers diverse options for managing urinary incontinence.
    • Treatment selection should be tailored to the specific type and cause of incontinence.
    • Further research may refine therapeutic strategies for improved patient outcomes.